M. Kirk

1210 PRE-EXISTENCE, EMERGENCE AND PERSISTENCE OF HCV GENOTYPE 4 NS5A RESISTANCE VARIANTS FROM THE PHASE 2B COMMAND-1 STUDY: DACLATASVIR PLUS PEGINTERFERON-alfa/ RIBAVIRIN IN TREATMENT-NAIVE PATIENTS

F. Mcphee, E. Hughes, N. Zhou, 2013 .

In Vitro Activity of Daclatasvir on Hepatitis C Virus Genotype 3 NS5A

Lingling Jia, M. Gao, R. Fridell, 2012, Antimicrobial Agents and Chemotherapy.

1194 CHARACTERIZATION OF VIRAL ESCAPE IN HCV GENOTYPE 1-INFECTED PATIENTS TREATED WITH BMS-791325 AND PEGYLATED INTERFERON-ALFA AND RIBAVIRIN

P. Fracasso, J. Lemm, D. McPhee, 2012 .

Intragenic Complementation of Hepatitis C Virus NS5A RNA Replication-Defective Alleles

M. Gao, R. Fridell, Dike Qiu, 2012, Journal of Virology.